| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | 961YV2O515 |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Myasthenia Gravis | 3 | D009157 | ClinicalTrials |
| Purpura, Thrombocytopenic, Idiopathic | 3 | D016553 | ClinicalTrials |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 | D020277 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297551 |
| FDA SRS | 961YV2O515 |
CONTENTS